A detailed history of Glen Eagle Advisors, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 433 shares of LNTH stock, worth $47,344. This represents 0.01% of its overall portfolio holdings.

Number of Shares
433
Holding current value
$47,344
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 03, 2024

BUY
$51.07 - $68.26 $22,113 - $29,556
433 New
433 $27 Million
Q3 2020

Aug 13, 2024

SELL
$11.98 - $16.34 $551 - $751
-46 Closed
0 $0
Q2 2020

Aug 13, 2024

SELL
$10.34 - $15.51 $4,001 - $6,002
-387 Reduced 89.38%
46 $658,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.52B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.